Lumiradx Ltd. has secured CE marking for its HbA1c test for diabetes. The point-of-care (POC), automated fingerstick assay is run on the Lumiradx portable platform and designed to provide connected results in under seven minutes, with a reportable range of 20-130 mmol/mol HbA1c (4.0% to 14.0% HbA1c).
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avadel, Biomind, Clearmind, Cynata, Hyundai, Innocare, Janssen, Merck, Pfizer, Reata, Revive, Roche, Scisparc, Servier.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Academab, Menarini, Mereo, Neurona, Neurosene, Total Brain, Verisim, Zymeworks.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrivo, Axcella, Cytomx, Laekna, Modus, Moleculin, Nurix, Q32, Scioto, Sellas, Tikomed, Yingli.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ellipses, Enlivex, Evgen, Insilico, Merck, Novocure, Novomedix, Oxford.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Codagenix, Crinetics, Endeavor, Harbour, Junshi, Karyopharm, Obseva, Osivax, Pharmazz.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antios, Assembly, Astrazeneca, Bavarian Nordic, Citius, Teva.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerie, Alnylam, Alvotech, Caladrius, Cingulate, Cytokinetics, Edesa, Eli Lilly, Ensysce, Luxa, Pfizer, Recardio, Springworks, Windtree.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altamira, Astrazeneca, Bharat, Biohaven, Depymed, Eiger, Greenwich, Immunitybio, Immunogen, Nymox, Ocugen, Regeneron, Salubris, Sanofi, Therapeuticsmd.
RSS
